Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 1.55M | 1.04% | $ 149.69M |
3/31/2025 | $ -5.3M | -3.57% | $ 148.52M |
12/31/2024 | $ -11.1M | -7.69% | $ 144.28M |
9/30/2024 | $ -27.46M | -19.94% | $ 137.74M |
6/30/2024 | $ -47.62M | -34.92% | $ 136.36M |
3/31/2024 | $ -80.45M | -60.9% | $ 132.1M |
12/31/2023 | $ -110.06M | -86.63% | $ 127.04M |
9/30/2023 | $ -118.87M | -96.77% | $ 122.84M |
6/30/2023 | $ -135.77M | -115.09% | $ 117.96M |
3/31/2023 | $ -150.07M | -131.84% | $ 113.83M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for HERON THERAPEUTICS INC is calculated as follows: EBIT [ $ -228.7M ] / Revenues [ $ 103.12M ]
(=) EBIT % [ -221.79% ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |